Self-suppressed quantum diffusion and fundamental noise limit of soliton microcombs

Quantum diffusion of soliton microcombs has long been recognized as their fundamental noise limit. Here we surpass such limit by utilizing dispersive wave dynamics in multimode microresonators. Through the recoil force provided by these dispersive waves, the quantum diffusion can be suppressed to a much lower level that forms the ultimate fundamental noise limit of soliton microcombs. Our findings enable coherence engineering of soliton microcombs in the quantum-limited regime, providing critical guidelines for using soliton microcombs to synthesize ultralow-noise microwave and optical signals.Comment: 8 pages, 5 figure

Health status prediction for the elderly based on machine learning

Health and social care services are crucial to old people. The provision of services to the elderly with care needs requires more accurate predictions of the health status of the elderly to rationalize the allocation of the limited social care resources. The traditional analytical methods have proved incapable of predicting the demands of today's society, compared to which machine learning methods can more accurately capture the nonlinear relationships between the variables. To ascertain visually the performance of these machine learning methods regarding the prediction of the elderly's care needs, we designed and verified the experiment

Does or did the supernova remnant Cassiopeia A operate as a PeVatron?

For decades, supernova remnants (SNRs) have been considered the prime sources of Galactic Cosmic rays (CRs). But whether SNRs can accelerate CR protons to PeV energies and thus dominate CR flux up to the knee is currently under intensive theoretical and phenomenological debate. The direct test of the ability of SNRs to operate as CR PeVatrons can be provided by ultrahigh-energy (UHE; $E_\gamma \geq 100$~TeV) $\gamma$-rays. In this context, the historical SNR Cassiopeia A (Cas A) is considered one of the most promising target for UHE observations. This paper presents the observation of Cas A and its vicinity by the LHAASO KM2A detector. The exceptional sensitivity of LHAASO KM2A in the UHE band, combined with the young age of Cas A, enabled us to derive stringent model-independent limits on the energy budget of UHE protons and nuclei accelerated by Cas A at any epoch after the explosion. The results challenge the prevailing paradigm that Cas A-type SNRs are major suppliers of PeV CRs in the Milky Way.Comment: 11 pages, 3 figures, Accepted by the APJ

Measurement of ultra-high-energy diffuse gamma-ray emission of the Galactic plane from 10 TeV to 1 PeV with LHAASO-KM2A

The diffuse Galactic $\gamma$-ray emission, mainly produced via interactions between cosmic rays and the interstellar medium and/or radiation field, is a very important probe of the distribution, propagation, and interaction of cosmic rays in the Milky Way. In this work we report the measurements of diffuse $\gamma$-rays from the Galactic plane between 10 TeV and 1 PeV energies, with the square kilometer array of the Large High Altitude Air Shower Observatory (LHAASO). Diffuse emissions from the inner ($15^{\circ}<l<125^{\circ}$, $|b|<5^{\circ}$) and outer ($125^{\circ}<l<235^{\circ}$, $|b|<5^{\circ}$) Galactic plane are detected with $29.1\sigma$ and $12.7\sigma$ significance, respectively. The outer Galactic plane diffuse emission is detected for the first time in the very- to ultra-high-energy domain ($E>10$~TeV). The energy spectrum in the inner Galaxy regions can be described by a power-law function with an index of $-2.99\pm0.04$, which is different from the curved spectrum as expected from hadronic interactions between locally measured cosmic rays and the line-of-sight integrated gas content. Furthermore, the measured flux is higher by a factor of $\sim3$ than the prediction. A similar spectrum with an index of $-2.99\pm0.07$ is found in the outer Galaxy region, and the absolute flux for $10\lesssim E\lesssim60$ TeV is again higher than the prediction for hadronic cosmic ray interactions. The latitude distributions of the diffuse emission are consistent with the gas distribution, while the longitude distributions show clear deviation from the gas distribution. The LHAASO measurements imply that either additional emission sources exist or cosmic ray intensities have spatial variations.Comment: 12 pages, 8 figures, 5 tables; accepted for publication in Physical Review Letters; source mask file provided as ancillary fil

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Random Access Preamble Generation with Low Storage for LTE Networks

Long Term Evolution (LTE) random access preambles are generated from cyclically shifted Zadoff-Chu(ZC) sequences of prime length by using so-called Discrete Fourier Transformation-Spread-Orthogonal Frequency Division Multiplexing (DFT-S-OFDM) modulation. In this paper we propose a novel preamble generation to reduce the storage and complexity of cyclically shifted ZC sequences’ Discrete Fourier Transformation (DFT). The proposed preamble generation allows the DFT of cyclically shifted ZC sequences to rely only on several constant factors and the elements of non-cyclically shifted ZC sequences which have already been generated. This preamble generation merely requires the storage of several constant factors, while avoids large storage and complex computation of complex exponential function

Random Access Preamble Generation with Low Storage for LTE Networks

Long Term Evolution (LTE) random access preambles are generated from cyclically shifted Zadoff-Chu(ZC) sequences of prime length by using so-called Discrete Fourier Transformation-Spread-Orthogonal Frequency Division Multiplexing (DFT-S-OFDM) modulation. In this paper we propose a novel preamble generation to reduce the storage and complexity of cyclically shifted ZC sequences’ Discrete Fourier Transformation (DFT). The proposed preamble generation allows the DFT of cyclically shifted ZC sequences to rely only on several constant factors and the elements of non-cyclically shifted ZC sequences which have already been generated. This preamble generation merely requires the storage of several constant factors, while avoids large storage and complex computation of complex exponential function

Design and Testing of a Self-Propelled Dandelion Seed Harvester

At present, there are few harvesters for dandelion (Taraxacum mongolicum) seeds, which limits the large-area planting of dandelion. Furthermore, manual harvesting is characterized by huge labor intensity, low efficiency, and high costs. Combining the material characteristics of dandelion plants and seeds with agronomic requirements for harvesting dandelion seeds, a self-propelled dandelion seed harvester was designed. The harvester is mainly composed of collection devices, separation devices, transmission devices, and a rack. It can facilitate seed collection from plants, seed transportation, and seed–pappus separation in one operation. The collection and separation processes of dandelion seeds were studied to ascertain the main factors that affect the collection rate. Then, the collection and separation devices were designed, and their parameters were analyzed. Taking the forward speed, wind velocity of blowers, and rate of rotation of the drum as test factors and the collection rate as the evaluation index, quadratic regression orthogonal rotating field tests were performed. In this way, the optimal combination of operation parameters was determined: the collection rate is optimal when the forward speed is 0.8 m·s−1, the air velocity from the blowers is 1.63 m·s−1, and the rate of rotation of the drum is 419 rpm. Field test results showed that a favorable harvesting effect was achieved after operation of the harvester, and only small amounts of dandelion seeds remained unharvested. Under the optimal parameter combination, the collection rate reached 89.1%, which could meet requirements for practical field harvesting of dandelion seeds. The test results satisfy the design requirement

Rupatadine Protects against Pulmonary Fibrosis by Attenuating PAF-Mediated Senescence in Rodents

<div><p>A similar immune response is implicated in the pathogenesis of pulmonary fibrosis and allergic disorders. We investigated the potential therapeutic efficacy and mechanism of rupatadine, a dual antagonist of histamine and platelet-activation factor (PAF), in bleomycin- (BLM-) and silica-induced pulmonary fibrosis. The indicated dosages of rupatadine were administered in rodents with bleomycin or silica-induced pulmonary fibrosis. The tissue injury, fibrosis, inflammatory cells and cytokines, and lung function were examined to evaluate the therapeutic efficacy of rupatadine. The anti-fibrosis effect of rupatadine was compared with an H1 or PAF receptor antagonist, and efforts were made to reveal rupatadine’s anti-fibrotic mechanism. Rupatadine promoted the resolution of pulmonary inflammation and fibrosis in a dose-dependent manner, as indicated by the reductions in inflammation score, collagen deposition and epithelial-mesenchymal transformation, and infiltration or expression of inflammatory cells or cytokines in the fibrotic lung tissue. Thus, rupatadine treatment improved the declined lung function and significantly decreased animal death. Moreover, rupatadine was able not only to attenuate silica-induced silicosis but also to produce a superior therapeutic efficacy compared to pirfenidone, histamine H1 antagonist loratadine, or PAF antagonist CV-3988. The anti-fibrotic action of rupatadine might relate to its attenuation of BLM- or PAF-induced premature senescence because rupatadine treatment protected against the <i>in vivo</i> and <i>in vitro</i> activation of the p53/p21-dependent senescence pathway. Our studies indicate that rupatadine promotes the resolution of pulmonary inflammation and fibrosis by attenuating the PAF-mediated senescence response. Rupatadine holds promise as a novel drug to treat the devastating disease of pulmonary fibrosis.</p> </div